The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis is a research paper published in Journal of Biological Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 236 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Japan Society for the Promotion of Science
Grant: 18K06903
National Institutes of Health
Ministry of Education, Culture, Sports, Science and Technology
National Heart, Lung, and Blood Institute
FWCI
6.76
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Additional file 1 of Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Additional file 7 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 7 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 2 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 4 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 1 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 3 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 2 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 6 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 4 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 6 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 1 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 3 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 5 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 5 of Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Additional file 1 of Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter
Additional file 1 of Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter